Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Gastroenterol

Retrieve available abstracts of 26 articles:
HTML format

Single Articles

    August 2021
  1. CAO Z, Qiu J, Guo J, Xiong G, et al
    A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.
    J Gastroenterol. 2021 Aug 28. pii: 10.1007/s00535-021-01818.
    PubMed     Abstract available

  2. MASAKI Y, Nakase H, Tsuji Y, Nojima M, et al
    The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis.
    J Gastroenterol. 2021 Aug 24. pii: 10.1007/s00535-021-01817.
    PubMed     Abstract available

    July 2021
  3. CANNON A, Thompson CM, Bhatia R, Armstrong KA, et al
    Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2021 Jul 19. pii: 10.1007/s00535-021-01800.
    PubMed     Abstract available

    A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.
    J Gastroenterol. 2021 Jul 13. pii: 10.1007/s00535-021-01806.
    PubMed     Abstract available

    June 2021
  5. KURIYAMA K, Kodama Y, Shiokawa M, Nishikawa Y, et al
    Essential role of Notch/Hes1 signaling in postnatal pancreatic exocrine development.
    J Gastroenterol. 2021 Jun 14. pii: 10.1007/s00535-021-01779.
    PubMed     Abstract available

    March 2021
  6. WANG WQ, Zhang WH, Gao HL, Huang D, et al
    A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
    J Gastroenterol. 2021 Mar 19. pii: 10.1007/s00535-021-01777.
    PubMed     Abstract available

    February 2021
  7. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.

  8. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.

    October 2020
  9. SAKAI A, Masuda A, Eguchi T, Anami T, et al
    Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation.
    J Gastroenterol. 2020 Oct 28. pii: 10.1007/s00535-020-01739.
    PubMed     Abstract available

  10. TEZUKA K, Okamura Y, Sugiura T, Ito T, et al
    The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    J Gastroenterol. 2020 Oct 22. pii: 10.1007/s00535-020-01730.
    PubMed     Abstract available

    September 2020
  11. OKADA T, Mizukami Y, Ono Y, Sato H, et al
    Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
    J Gastroenterol. 2020 Sep 16. pii: 10.1007/s00535-020-01724.
    PubMed     Abstract available

    July 2020
  12. DUNBAR E, Greer PJ, Melhem N, Alkaade S, et al
    Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort.
    J Gastroenterol. 2020 Jul 17. pii: 10.1007/s00535-020-01703.
    PubMed     Abstract available

  13. MASAMUNE A, Kikuta K, Kume K, Hamada S, et al
    Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
    J Gastroenterol. 2020 Jul 16. pii: 10.1007/s00535-020-01704.
    PubMed     Abstract available

    June 2020
  14. BHARMAL SH, Cho J, Alarcon Ramos GC, Ko J, et al
    Trajectories of glycaemia following acute pancreatitis: a prospective longitudinal cohort study with 24 months follow-up.
    J Gastroenterol. 2020 Jun 3. pii: 10.1007/s00535-020-01682.
    PubMed     Abstract available

    May 2020
  15. ITO T, Tanaka T, Nakamaru K, Tomiyama T, et al
    Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis.
    J Gastroenterol. 2020 May 6. pii: 10.1007/s00535-020-01689.
    PubMed     Abstract available

    February 2020
  16. HAMADA T, Ogino S, Wolpin BM
    Response to the letter by Lai et al. regarding our manuscript "Statin use and pancreatic cancer risk in two prospective cohort studies".
    J Gastroenterol. 2020 Feb 14. pii: 10.1007/s00535-020-01676.

  17. LAI SW, Kuo YH, Liao KF
    Statins and pancreatic cancer risk.
    J Gastroenterol. 2020 Feb 8. pii: 10.1007/s00535-020-01675.

    January 2020
  18. OKUSAKA T, Furuse J
    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.
    J Gastroenterol. 2020 Jan 29. pii: 10.1007/s00535-020-01666.
    PubMed     Abstract available

  19. MINAGA K, Watanabe T, Arai Y, Shiokawa M, et al
    Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis.
    J Gastroenterol. 2020 Jan 20. pii: 10.1007/s00535-020-01662.
    PubMed     Abstract available

    December 2019
  20. MASAMUNE A, Kikuta K, Hamada S, Tsuji I, et al
    Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
    J Gastroenterol. 2019 Dec 23. pii: 10.1007/s00535-019-01658.
    PubMed     Abstract available

  21. KURITA Y, Hara K, Kuwahara T, Mizuno N, et al
    Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    J Gastroenterol. 2019 Dec 19. pii: 10.1007/s00535-019-01655.
    PubMed     Abstract available

  22. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    J Gastroenterol. 2019 Dec 6. pii: 10.1007/s00535-019-01652.
    PubMed     Abstract available

    November 2019
  23. HIROTA M, Shimosegawa T, Kitamura K, Takeda K, et al
    Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial.
    J Gastroenterol. 2019 Nov 22. pii: 10.1007/s00535-019-01644.
    PubMed     Abstract available

    September 2019
  24. LIU Y, Wang D, Li ZS, Hu LH, et al
    Study of early chronic pancreatitis needs to be improved.
    J Gastroenterol. 2019 Sep 26. pii: 10.1007/s00535-019-01632.

  25. KIKUTA K, Masamune A
    Reply to "Study of Early Chronic Pancreatitis Needs to be Improved".
    J Gastroenterol. 2019 Sep 23. pii: 10.1007/s00535-019-01631.

    August 2019
  26. HAKUTA R, Hamada T, Nakai Y, Oyama H, et al
    Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes.
    J Gastroenterol. 2019 Aug 31. pii: 10.1007/s00535-019-01612.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.